BLUEBERRIES MEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 CAD | 0.00% |
|
+33.33% | 0.00% |
| 26/04 | Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Blueberries Medical Corp. announced that it has received CAD 1.987876 million in funding | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 14.84 | 12.67 | 11.47 | 4.366 | 7.981 |
| Enterprise Value (EV) 1 | 13.02 | 13.86 | 11.56 | 4.29 | 7.175 |
| P/E ratio | -1.21 x | -2.51 x | -2.02 x | -2.3 x | -2.68 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 19,20,36,482 x | 8,26,44,800 x | 1,85,44,071 x | 2,76,83,934 x |
| EV / Revenue | - | 21,00,05,896 x | 8,33,34,559 x | 1,82,19,899 x | 2,48,90,204 x |
| EV / EBITDA | -1.99 x | -3.88 x | -10.7 x | -3.18 x | -5.84 x |
| EV / FCF | -22,90,165 x | -1,39,54,160 x | -57,26,808 x | -27,79,429 x | -59,96,220 x |
| FCF Yield | -0% | -0% | -0% | -0% | -0% |
| Price to Book | 1.84 x | 3.26 x | 7.99 x | 2.97 x | 4.1 x |
| Nbr of stocks (in thousands) | 1,23,702 | 1,26,702 | 1,63,810 | 2,18,309 | 3,99,025 |
| Reference price 2 | 0.1200 | 0.1000 | 0.0700 | 0.0200 | 0.0200 |
| Announcement Date | 29/04/20 | 30/04/21 | 03/05/22 | 24/04/23 | 26/04/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 0.066 | 0.1387 | 0.2354 | 0.2883 |
| EBITDA 1 | -1.599 | -6.533 | -3.571 | -1.085 | -1.349 | -1.228 |
| EBIT 1 | -1.617 | -6.799 | -4.125 | -1.789 | -1.641 | -1.376 |
| Operating Margin | - | - | -6,251.54% | -1,289.55% | -696.79% | -477.44% |
| Earnings before Tax (EBT) 1 | -1.607 | -10.79 | -4.94 | -5.147 | -1.468 | -1.635 |
| Net income 1 | -1.607 | -10.79 | -4.94 | -5.147 | -1.468 | -1.635 |
| Net margin | - | - | -7,487.51% | -3,709.64% | -623.44% | -567.3% |
| EPS 2 | -0.0334 | -0.0990 | -0.0399 | -0.0347 | -0.008691 | -0.007457 |
| Free Cash Flow | - | -5.685 | -0.9929 | -2.019 | -1.543 | -1.197 |
| FCF margin | - | - | -1,504.97% | -1,455.17% | -655.53% | -415.1% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 23/04/19 | 29/04/20 | 30/04/21 | 03/05/22 | 24/04/23 | 26/04/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.02 | - | 1.19 | 0.1 | - | - |
| Net Cash position 1 | - | 1.83 | - | - | 0.08 | 0.81 |
| Leverage (Debt/EBITDA) | -0.0107 x | - | -0.332 x | -0.0882 x | - | - |
| Free Cash Flow | - | -5.68 | -0.99 | -2.02 | -1.54 | -1.2 |
| ROE (net income / shareholders' equity) | - | -235% | -82.6% | -193% | -101% | -95.8% |
| ROA (Net income/ Total Assets) | - | -72.9% | -30.2% | -20.6% | -29.5% | -29.8% |
| Assets 1 | - | 14.79 | 16.34 | 25 | 4.973 | 5.486 |
| Book Value Per Share 2 | 0.0200 | 0.0700 | 0.0300 | 0.0100 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | 0 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.04 | 4.52 | 0.83 | 0.01 | - | 0.02 |
| Capex / Sales | - | - | 1,261.29% | 6.88% | - | 7.75% |
| Announcement Date | 23/04/19 | 29/04/20 | 30/04/21 | 03/05/22 | 24/04/23 | 26/04/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 5.86M | |
| +16.68% | 3.07B | |
| +12.07% | 1.77B | |
| +100.63% | 671M | |
| +4.09% | 527M | |
| +53.52% | 174M | |
| -12.66% | 94.91M | |
| +43.75% | 63.28M | |
| +33.71% | 57.02M |
- Stock Market
- Equities
- BBM Stock
- Financials Blueberries Medical Corp.